As Previously Reported, SONICS Met its Primary Endpoint With 30 Percent of the ITT Patient Population Reaching & Maintaining Mean Urinary Free Cortisol (mUFC) Normalization Following Six Months of Maintenance Therapy Without a Dose Increase ~ ~ RECORLEV Monotherapy Normalized UFC Initially in... read more

Mölndal, October 22, 2018 - Due to personal reasons, Göran Wessman has chosen to resign from the Board of Directors of Vicore Pharma Holding AB (publ) and will instead join the nomination committee of Vicore Pharma Holding AB (publ) as representative of Protem Wessman AB. Göran Wessman, board ... read more

25 independent distributors contracted Total of 512 distributor reps now selling CERAMENT BVF New distribution network will positively impact North American reported sales and net margins Lund, Sweden, 08:00 CET, 22 October 2018 - BONESUPPORT, an emerging leader in orthobiologics for... read more

• Clinically meaningful improvement of +15 ETDRS letters in visual acuity of treated eyes at Week 72 • Continuous bilateral improvement of both visual acuity and contrast sensitivity • Significantly higher proportion of drug-treated eyes achieved clinically meaningful improvement in contrast... read more

Oslo, Norway, 17 October 2018 Nordic Nanovector ASA (OSE: NANO) announces it will present its results for the third quarter 2018 on Tuesday, 6 November 2018 (previously scheduled for Tuesday, 21 November), and will host a results presentation and webcast on the same day (details will be... read more